Home/Pipeline/AcipHex® Sprinkle

AcipHex® Sprinkle

GERD, H. pylori eradication (pediatric)

Approved/CommercialMarketed

Key Facts

Indication
GERD, H. pylori eradication (pediatric)
Phase
Approved/Commercial
Status
Marketed
Company

About Aytu BioScience

Aytu BioScience is a commercial-stage biopharmaceutical company with a mission to identify, acquire, and commercialize novel therapeutics for patients with high unmet medical needs. Its strategy centers on building a diversified portfolio of commercial products and late-stage development candidates, primarily in rare pediatric and central nervous system disorders. The company generates revenue from its commercial assets while advancing its pipeline to drive future growth. Aytu's focus on underserved markets aims to create significant value for patients and shareholders.

View full company profile